Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Doxorubicin and Ifosfamide in Adult Soft Tissue Sarcoma
NCT00001300Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 1992
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, ifosfamide in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Jun 1992; status: completed.
02
Drugs
doxorubicinifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00001300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001300.